Revere Partners, the institutional venture capital fund focused on investing at the intersection of health and oral health technology, announced today its return to the Yankee Dental Congress with its fifth consecutive “Future of Dentistry Pavilion,” highlighting emerging technologies that are shaping the evolution of dental care and medical-dental integration.
Located at Booth #2034, the 2026 Revere Innovation Pavilion will center on the theme “Liquid Gold,” spotlighting saliva as a critical diagnostic and biological driver of overall health and regenerative technologies. The pavilion will feature a curated group of early- and growth-stage companies approaching the saliva opportunity from diverse clinical, scientific, workflow, and business perspectives.
“It’s an honor to collaborate once again with the Yankee Dental Congress, as we share a strong mutual interest in accelerating the adoption of dental technology,” said Dr. Jeremy Krell, founder of Revere Partners.
The 2026 Future of Dentistry Pavilion will feature companies utilizing saliva to advance continuous health monitoring, oral cancer diagnostics, regenerative therapies, and implant stabilization technologies, reinforcing Revere Partners’ mission to support innovations that improve patient outcomes and provider experiences. The dental innovators will include:
Over the past five years, Revere Partners’ presence at the Yankee Dental Congress has provided exposure to dozens of innovative startups, connecting founders with clinicians, industry leaders, and strategic partners seeking next-generation solutions in oral and systemic health. “Our goal has always been to provide meaningful exposure to companies driving patient-centered care, solving critical provider care gaps, and propelling medical-dental integration and whole-person care,” added Krell.
About Revere Partners
Revere Partners is the first institutional venture capital fund focused on oral and systemic health, identifying groundbreaking opportunities for investors and providing capital for cutting-edge innovations. Revere Partners aligns startups with strategic capital alongside unrivaled industry resources and growth opportunities. Founded by Dr. Jeremy Krell, Revere Partners fosters strategic partnerships that enhance care delivery while maximizing value for investors.
Source: www.reverepartnersvc.com
News 10 November 2026
MegaGen Implant, a global dental implant specialist, announced today that it has established a new philanthropic partnership with the Herman Ostrow School of Dentistry at the Unive
News 28 October 2026
Specialty1 Partners (S1P) , the leading doctor-founded, doctor-led specialty dental partnership organization, is embracing the future of healthcare through strategic investments in
Key transaction by Heartland Dental and its supported practices expands opportunities for supported doctors, teams, and practices while strengthening Heartland Dental’s supported f
News 09 October 2026
Apex Dental Partners, a dental partnership organization supporting dentists and affiliated practices, has been named No.
News 21 September 2026
BlancOne® Click+ introduces a simple 10-minute professional teeth-whitening experience designed to integrate into existing hygiene appointments, helping dental practices create new
Products 18 November 2026
News 18 November 2026
Angelalign Technology Appoints Marco Gadola as Senior Advisor
(6699.HK) (“Angel”), a global clear aligner leader, recently announced that Marco Gadola has joined the company as Senior Advisor.
News 18 November 2026
(“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exo
Editorials 18 November 2026
The Pediatric Dentistry Alumni Association supports the IU Pediatric Dentistry Department and students in a variety of ways.
Orthodontics 18 November 2026
This peer-reviewed orthodontics article summarizes clinical evidence from Dental press journal of orthodontics (2024). It focuses on findings that may help dental professionals evaluate treatment...